QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2017    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status 期刊论文 SCIENTIFIC REPORTS, 2017, 卷号: 7 作者:  Jian, Hong;  Li, Wei;  Ma, Zhiyong;  Huang, Jianjin;  Feng, Jifeng 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Safety and tolerability profile of raltitrexed in Chinese patients with locally advanced or recurrent and metastatic colorectal cancer: A phase IV trial. 会议论文 作者:  Qin, Shukui;  Li, Jin;  Liu, Yunpeng;  Chen, Yin;  Xu, Nong 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29, 期号: 4 作者:  Li, Jian 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Gastrointestinal stromal tumor  diagnosis  therapy  consensus   Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10 作者:  Liu, Xinyang;  Qin, Shukui;  Wang, Zhichao;  Xu, Jianming;  Xiong, Jianping 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Apatinib  Gastric cancer  Biomarker  Adverse events   Recombinant Human Endostatin and/or Cisplatin in Treatment of Malignant Hydrothorax and Ascites: A Multicenter Randomized Study 会议论文 作者:  Qin, Shukui;  Cheng, Ying;  Tan, Qinghe;  Bi, Jingwang;  Wang, Liwei 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 Recombinant human endostatin  Malignant hydrothorax  Malignant ascites  Endostar   The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors. 会议论文 作者:  Raymond, Eric;  Kulke, Matthew H.;  Qin, Shukui;  Schenker, Michael;  Cubillo, Antonio 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 The Efficacy and Safety of Sunitinib in Patients With Advanced Well-differentiated Pancreatic Neuroendocrine Tumors 会议论文 作者:  Raymond, Eric;  Kulke, Matthew;  Qin, Shukui;  Schenker, Michael;  Cubillo, Antonio 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Impact of primary tumor location (TL) on outcomes of first-line (1L) FOLFOX-4 (F) +/- cetuximab (cet) in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase 3 TAILOR trial 会议论文 作者:  Qin, Shukui;  Xu, Jian-Ming;  Wang, Liwei;  Cheng, Ying;  Liu, Tian Shu 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Therapeutic effect of apatinib on overall survival is mediated by prolonged progression-free survival in advanced gastric cancer patients 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 17 作者:  Huang, Lihong;  Wei, Yongyue;  Shen, Sipeng;  Shi, Qianwen;  Bai, Jianling 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 apatinib  gastric cancer  overall survival  progression-free survival  mediation analysis